Charles Flexner
- Virology top 0.05%
- HIV Research and Treatment 93
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment 109
- HIV/AIDS Research and Interventions 56
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 25
- Immunology top 1%
- Immune Cell Function and Interaction 15
- Epidemiology top 1%
- Pneumocystis jirovecii pneumonia detection and treatment 27
- Herpesvirus Infections and Treatments 8
-
- Hepatitis C virus research 13
- Co-authors
- Bernard MossBruce D. WalkerRichard E. ChaissonRobert F. SilicianoJoel E. GallantRoy M. GulickThomas C. QuinnJanet D. Siliciano
- Journals
- Clinical Infectious Diseases (16 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (16 papers)Antimicrobial Agents and Chemotherapy (12 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Charles Flexner
176 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Virology 5.3k
- Infectious Diseases 5.7k
- Emergency Medicine 921
- Immunology 1.9k
- Epidemiology 2.4k
Countries citing papers authored by Charles Flexner
This map shows the geographic impact of Charles Flexner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Flexner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Flexner more than expected).
Fields of papers citing papers by Charles Flexner
This network shows the impact of papers produced by Charles Flexner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Flexner. The network helps show where Charles Flexner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Flexner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 22 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 25 | |
| 7 | 2018 | 76 | |
| 8 | 2018 | 36 | |
| 9 | 2013 | 10 | |
| 10 | 2012 | 143 | |
| 11 | 2010 | 8 | |
| 12 | 2010 | 29 | |
| 13 | 2010 | 23 | |
| 14 | 2007 | 4 | |
| 15 | 2007 | 195 | |
| 16 | 2006 | 8 | |
| 17 | HLA B57 and abacavir hypersensitivity. | 2002 | 2 |
| 18 | 2002 | 64 | |
| 19 | 2002 | 47 | |
| 20 | 1998 | 160 |
About Charles Flexner
Charles Flexner is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 181 papers that have together received 10.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (109 papers), HIV Research and Treatment (93 papers), HIV/AIDS Research and Interventions (56 papers), Pneumocystis jirovecii pneumonia detection and treatment (27 papers), HIV-related health complications and treatments (25 papers), Immune Cell Function and Interaction (15 papers), Hepatitis C virus research (13 papers) and Herpesvirus Infections and Treatments (8 papers). The work is most often cited by research in Virology (5.3k citations), Infectious Diseases (5.7k citations) and Emergency Medicine (921 citations). Charles Flexner has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Bernard Moss, Bruce D. Walker, Richard E. Chaisson, Robert F. Siliciano, Joel E. Gallant, Roy M. Gulick, Thomas C. Quinn, Janet D. Siliciano, Julianna Lisziewicz and Diana Finzi. Their work appears in journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.